Company

Naveris Inc.

Naveris develops blood tests for early detection and monitoring of HPV-related cancers.

About

Founded in 2017 and based in Natick, US, Naveris develops NavDx®, a blood test for detecting and monitoring HPV-related cancers. In September 2022, it raised USD 33.4 mn in Series A funding led by Gurnet Point Capital, with BrightEdge Ventures and TechU Ventures participating.

4Funding rounds

5Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in